Structural and molecular insights into the mechanism of resistance to enzalutamide by the clinical mutants in androgen receptor (AR) in castration-resistant prostate cancer (CRPC) patients-Reference-Cited by-同舟云学术

Structural and molecular insights into the mechanism of resistance to enzalutamide by the clinical mutants in androgen receptor (AR) in castration-resistant prostate cancer (CRPC) patients

Published:2022-10 Issue: Volume:218 Page:856-865
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Khan Abbas,Mao Yuanshen,Tahreem Sana,Wei Dong-Qing,Wang Yanjing

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference51 articles.

1. Epidemiology of prostate cancer;Crawford;Urology,2003

2. Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer;Azad;Clin. Cancer Res.,2015

3. A history of prostate cancer treatment;Denmeade;Nat. Rev. Cancer,2002

4. Integrative clinical genomics of advanced prostate cancer;Robinson;Cell,2015

5. Transcriptional network of androgen receptor in prostate cancer progression;Takayama;Int. J. Urol.,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular modeling and simulation approaches to characterize potential molecular targets for burdock inulin to instigate protection against autoimmune diseases;Scientific Reports;2024-05-17

2. Genetic Signatures for Distinguishing Chemo-Sensitive from Chemo-Resistant Responders in Prostate Cancer Patients;Current Issues in Molecular Biology;2024-03-11

3. Structure-guided engineering and molecular simulations to design a potent monoclonal antibody to target aP2 antigen for adaptive immune response instigation against type 2 diabetes;Frontiers in Immunology;2024-03-08

4. Network pharmacology, molecular simulation, and binding free energy calculation-based investigation of Neosetophomone B revealed key targets for the treatment of cancer;Frontiers in Pharmacology;2024-02-15

5. Targeting Human progesterone receptor (PR), through Pharmacophore- based screening and molecular simulation revealed potent inhibitors against breast cancer;2023-09-26